Effect of Virechana Karma and Mandura Vajra tablet in the treatment of Iron Deficiency Anaemia.
Not Applicable
- Conditions
- Health Condition 1: null- Iron Deficiency Anaemia
- Registration Number
- CTRI/2017/03/008141
- Lead Sponsor
- IPGT RA GAU Jamnagar Gujarat India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patient having clinical sign & symptoms of Pandu
Patients having low Hb % (WHO Criteria)
For female 8 to 11gm%
For male 8 to 13gm%
Patients having low serum Iron (Normal Range is in male 59 to 148 μg/dl and
female 37 to 145 μg/dl)
MCV less than 80 fl
Patients having low serum ferritin. (Normal Range is in male 25 to 280 ng/ml and female less than 73.3 ng/ml)
Exclusion Criteria
Patients unfit for the Virechana
Patients suffering from severe illnesses from AIDS, Cancer, Hypertension, Diabetes Mellitus & other severe diseases.
Haematological disorders like Sickle cell Anaemia, Thalassemia etc.
Pregnancy & lactating women
Patients having Hb < 8gm%.
Age below 18 years & more than 60 years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement will be assessed on the basis of <br/ ><br>relief found in cardinal symptoms of <br/ ><br>disease <br/ ><br>Progress in the signs and symptoms <br/ ><br>based on the standard pattern will be applied <br/ ><br>before and after treatment <br/ ><br>the work will also useful in management of Iron Deficiency AnaemiaTimepoint: 2 month of treatment and one month of follow up
- Secondary Outcome Measures
Name Time Method This study will help for the patients who suffers from iron deficiency anaemia and provide symptomatic reliefTimepoint: 3 month